Keiko Kataoka

12PUBLICATIONS
8CO-AUTHORS
Optical technologyVision scienceCancer geneticsClinimetricsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Oct 13, 2025
Treatment outcomes of switching to aflibercept 8 mg in previously-treated neovascular age-related macular degeneration.

Keiko Kataoka, Koji Tanaka, Junichiro Honjyo

|Jun 26, 2025
Comparison of intraocular pressure elevation following intravitreal injection of 70 µl aflibercept 8 mg.

Xien Lu, Keiko Kataoka, Mariko Kumagai

|May 10, 2025
Factors predictive of treatment outcomes in submacular hemorrhage secondary to age-related macular degeneration.

Yuto Watanabe, Takashi Koto, Aya Takahashi

|Apr 14, 2025
Simultaneous GA and CNV/MNV: incidence, characteristics, and treatments.

Keiko Kataoka, Richard Gale, Xiaoxin Li

|Dec 02, 2024
FACTORS PREDICTIVE OF PERSISTENT SUBRETINAL FLUID IN ACUTE CENTRAL SEROUS CHORIORETINOPATHY.

Chika Hatakeyama, Keiko Kataoka, Yuji Yoshikawa

|Aug 31, 2024
Clinical utility of swept-source optical coherence tomography angiography for the diagnosis of exudative maculopathy.

Ai Fujita Sajiki, Keiko Kataoka, Jun Takeuchi

Pageof 2